TMAM
ALXN

Tokio Marine Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Tokio Marine Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,411
Closed -$4.12M – 490
2021
Q2 		$4.12M Sell
22,411
-15,316
-41% -$2.63M 0.38% 47
2021
Q1 		$5.77M Buy
37,727
+213
+0.6% +$32.9K 0.59% 40
2020
Q4 		$5.86M Sell
37,514
-1,118
-3% -$144K 0.64% 37
2020
Q3 		$4.42M Sell
38,632
-16,038
-29% -$1.73M 0.55% 40
2020
Q2 		$6.14M Buy
54,670
+249
+0.5% +$26.4K 0.87% 33
2020
Q1 		$4.89M Buy
54,421
+277
+0.5% +$27.2K 0.84% 39
2019
Q4 		$5.86M Buy
54,144
+13,163
+32% +$1.41M 0.89% 31
2019
Q3 		$4.01M Buy
40,981
+4,469
+12% +$504K 0.67% 38
2019
Q2 		$4.78M Buy
36,512
+116
+0.3% +$15K 0.84% 31
2019
Q1 		$4.92M Buy
36,396
+95
+0.3% +$11.8K 0.91% 29
2018
Q4 		$3.53M Buy
36,301
+64
+0.2% +$7.57K 0.71% 40
2018
Q3 		$5.04M Buy
36,237
+21,555
+147% +$2.7M 0.88% 32
2018
Q2 		$1.82M Sell
14,682
-201
-1% -$23.5K 0.33% 66
2018
Q1 		$1.66M Sell
14,883
-413
-3% -$49.4K 0.29% 69
2017
Q4 		$1.83M Sell
15,296
-490
-3% -$59.7K 0.28% 93
2017
Q3 		$2.21M Sell
15,786
-2,347
-13% -$319K 0.33% 85
2017
Q2 		$2.21M Sell
18,133
-1,239
-6% -$144K 0.32% 86
2017
Q1 		$2.35M Buy
19,372
+14,911
+334% +$1.92M 0.31% 97
2016
Q4 		$546K Sell
4,461
-1,729
-28% -$212K 0.06% 202
2016
Q3 		$759K Sell
6,190
-829
-12% -$107K 0.08% 188
2016
Q2 		$820K Sell
7,019
-59
-0.8% -$8.37K 0.08% 191
2016
Q1 		$985K Buy
7,078
+203
+3% +$29.8K 0.1% 174
2015
Q4 		$1.31M Sell
6,875
-583
-8% -$102K 0.15% 140
2015
Q3 		$1.17M Buy
7,458
+380
+5% +$69.3K 0.12% 156
2015
Q2 		$1.28M Sell
7,078
-970
-12% -$167K 0.13% 157
2015
Q1 		$1.4M Sell
8,048
-1,218
-13% -$220K 0.13% 149
2014
Q4 		$1.71M Sell
9,266
-2,951
-24% -$547K 0.15% 144
2014
Q3 		$2.03M Sell
12,217
-1,160
-9% -$190K 0.15% 158
2014
Q2 		$2.09M Hold
13,377
– – 0.14% 151
2014
Q1 		$2.04M Sell
13,377
-618
-4% -$98.3K 0.13% 158
2013
Q4 		$1.86M Sell
13,995
-1,594
-10% -$191K 0.12% 180
2013
Q3 		$1.81M Sell
15,589
-703
-4% -$77.1K 0.12% 186
2013
Q2 		$1.5M Buy
+16,292
New +$1.57M 0.1% 221

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Tokio Marine Asset Management's ALXN Position: Q3 2021 in Review

Tokio Marine Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 22,411 shares — an estimated $4.12M sold.

Tokio Marine Asset Management first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $6.14M in Q2 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Tokio Marine Asset Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Tokio Marine Asset Management sold 22,411 Alexion Pharmaceuticals shares in Q3 2021, an estimated $4.12M.
  • Tokio Marine Asset Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • Tokio Marine Asset Management's Alexion Pharmaceuticals position peaked at $6.14M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Tokio Marine Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.